ANBL1232

Study Title: 
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma. A Groupwide Historically Controlled Phase III Study
Lead Group: 
Status: 
Review Status: